Showing posts from November, 2017

Treatments of exclusion.

Cultural insensitivity.

An unnecessary evil.

Coffee CAR-T.

SOLE cycle.

The cyclin don’t stop.

PROMISing answers for our intermediate risk Oncotypes.

More bad news for bev.

GBM needs a GPS.

There’s no “I” in cure.

Put this on your RADAR.

Chemo brain.

Another adjuvant Avastin letdown.

Brut-al disparities.

Roy Moore, Louis CK and Tamoxifen.

Pembro promises Merck-y results in sarcoma.

TACEt the rainbow.

I just wanna know where da GOLD at.

Cancer incognito.

Response requisites.

Gut check.

MARCHing to the beat of the same old drum.

Classical elements.

The fiber forecast.

A no-brainer addition to PCI.

Affordable care assessment.

(Mis)sensible information.

Academic atrophy.

Spicy hot.

A brachy bonus.